Microencapsulated phages show prolonged stability in gastrointestinal environments and high therapeutic efficiency to treat Escherichia coli O157:H7 infection

Escherichia coli (E. coli) O157:H7 bacterial infection causes severe disease in mammals and results in substantial economic losses worldwide. Due to the development of antibiotic resistance, bacteriophage (phage) therapy has become an alternative to control O157:H7 infection. However, the therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Hanjie, Li, Jing, Huang, Haosheng, Wang, Yuxin, Qian, Xinjie, Ren, Jianluan, Xue, Feng, Dai, Jianjun, Tang, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439058/
https://www.ncbi.nlm.nih.gov/pubmed/34521472
http://dx.doi.org/10.1186/s13567-021-00991-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439058/
https://www.ncbi.nlm.nih.gov/pubmed/34521472
http://dx.doi.org/10.1186/s13567-021-00991-1

Ejemplares similares